Skip navigation

Evaluation Methods & Risk Mitigation Strategies to Drive an Effective Diligence Process

November 30-December 1, 2017
  • Philadelphia, PA

Join us at CBI’s Due Diligence for Life Sciences M&A, Partnerships and Divestitures to gain tactical strategies from life sciences corporate development, business development and legal experts to benchmark your diligence process. This event delivers advanced strategies on how to conduct thorough diligence when evaluating products, partnerships and/or portfolio management decisions.

TOPICS TO INCLUDE:

  • Diligence, Deals and Market Dynamics
    • How financial markets are impacting current deals
    • Valuation strategies and the latest developments in deal structuring trends
    • Qualitative and quantitative modeling
    • Update on the M&A landscape
  • Commercial Diligence
    • Business development evaluation methodologies
    • Pre-partnership engagement factors
  • Intellectual Property / Patent Research Best Practices for Target Portfolio Assessment
  • Financial Diligence, Taxation Diligence and Antitrust Regulations
  • Quality and Clinical Diligence Best Practices
  • Post-Merger Diligence
    • Integration Models, Value Creation and Employee Engagement
  • Portfolio Management Strategies — Weighing When to Sell

Due Diligence for Life Sciences M&A, Partnerships and Divestitures

Evaluation Methods & Risk Mitigation Strategies to Drive an Effective Diligence Process

Join us at CBI’s Due Diligence for Life Sciences M&A, Partnerships and Divestitures to gain tactical strategies from life sciences corporate development, business development and legal experts to benchmark your diligence process. This event delivers advanced strategies on how to conduct thorough diligence when evaluating products, partnerships and/or portfolio management decisions.

TOPICS TO INCLUDE:

  • Diligence, Deals and Market Dynamics
    • How financial markets are impacting current deals
    • Valuation strategies and the latest developments in deal structuring trends
    • Qualitative and quantitative modeling
    • Update on the M&A landscape
  • Commercial Diligence
    • Business development evaluation methodologies
    • Pre-partnership engagement factors
  • Intellectual Property / Patent Research Best Practices for Target Portfolio Assessment
  • Financial Diligence, Taxation Diligence and Antitrust Regulations
  • Quality and Clinical Diligence Best Practices
  • Post-Merger Diligence
    • Integration Models, Value Creation and Employee Engagement
  • Portfolio Management Strategies — Weighing When to Sell